Cosmos Health Inc. balance sheet
At the end of fiscal 2025, Cosmos Health Inc. had total assets of $65.5m, total liabilities of $47.1m and shareholders' equity of $18.4m. It held $715,674 in cash against $15.6m of debt.
Balance sheet
| Fiscal year | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 21 | 4 | 0 | 1 | 2 |
| Receivables | — | — | 0 | 1 | 1 | 5 | — | — | — | 24 | 20 | 13 | 20 | 19 |
| Inventory | — | — | — | — | — | 3 | 3 | 3 | 3 | 3 | 5 | 4 | 6 | 5 |
| Total current assets | 1 | 7 | 1 | 3 | 10 | 18 | 21 | 41 | 40 | 56 | 37 | 25 | 38 | 37 |
| Goodwill | — | — | — | — | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total assets | 1 | 7 | 1 | 3 | 11 | 21 | 24 | 44 | 49 | 68 | 66 | 54 | 65 | 61 |
| Accounts payable | — | — | 0 | 3 | 10 | 10 | — | — | — | — | — | — | — | — |
| Deferred revenue (current) | — | — | — | — | — | — | — | — | — | — | — | — | 1 | 2 |
| Total current liabilities | — | 2 | 2 | 5 | 14 | 22 | 28 | 34 | 30 | 22 | 24 | 26 | 38 | 35 |
| Short-term debt | — | — | — | — | — | — | — | — | — | — | 2 | — | — | — |
| Long-term debt | — | — | — | — | — | 0 | 0 | 11 | 0 | 5 | 1 | 4 | 4 | 3 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 10 | 14 | 24 | 24 | 26 | 11 | 11 | 16 | 12 |
| Total liabilities | 1 | 2 | 2 | 5 | 14 | 24 | 30 | 48 | 45 | 28 | 30 | 30 | 47 | 41 |
| Shareholders' equity | −0 | 5 | −1 | −2 | −3 | −3 | −6 | −4 | 4 | 39 | 36 | 25 | 18 | 21 |
| Shares outstanding | — | — | — | — | — | — | — | — | 2m | — | — | 24m | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 17 | 13 | 14 | 15 | 18 | 20 | 18 | 19 |
| Inventory | 5 | 4 | 5 | 5 | 6 | 6 | 6 | 5 |
| Total current assets | 36 | 25 | 28 | 31 | 38 | 38 | 37 | 37 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total assets | 65 | 54 | 57 | 62 | 69 | 65 | 62 | 61 |
| Deferred revenue (current) | — | — | — | — | — | 1 | 2 | 2 |
| Total current liabilities | 25 | 26 | 27 | 31 | 39 | 38 | 34 | 35 |
| Long-term debt | 4 | 4 | 5 | 5 | 5 | 4 | 3 | 3 |
| Total debt | 4 | 4 | 5 | 5 | 5 | 4 | 3 | 3 |
| Total liabilities | 30 | 30 | 31 | 36 | 46 | 47 | 43 | 41 |
| Shareholders' equity | 35 | 25 | 26 | 26 | 23 | 18 | 20 | 21 |
| Shares outstanding | 23m | 24m | 27m | 30m | 32m | 41m | 41m | 81m |
Compare with peers
- Cellyan Biotechnology Co., Ltd balance sheet
- 111, Inc. balance sheet
- Henry Schein balance sheet
- Cencora balance sheet
- McKesson balance sheet
Head to head: COSM vs HKPDCOSM vs YICOSM vs HSIC
More: Health Care Distributors stocks compared, Health Care sector, rankings of US companies